More parents are refusing vitamin K shots for newborns, doctors say. Here’s why that could be dangerous23. Januar 2026
Health Avanzanite Bioscience Secures €32M Series A Investment from MVM PartnersHealthradar22. November 2025 MVM Partners joins as Avanzanite’s first institutional investor. Funding will scale Avanzanite’s existing infrastructure in all 32 countries in Europe,…
